Rationale and design of the cangrelor versus standard therapy to achieve optimal management of platelet inhibition PHOENIX trial

Sergio Leonardi, Kenneth W. Mahaffey, Harvey D. White, C. Michael Gibson, Gregg W. Stone, Gabriel W. Steg, Christian W. Hamm, Matthew J. Price, Meredith Todd, Markus Dietrich, Dianne Gallup, Tiepu Liu, Simona Skerjanec, Robert A. Harrington, Deepak L. Bhatt

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Rationale and design of the cangrelor versus standard therapy to achieve optimal management of platelet inhibition PHOENIX trial'. Together they form a unique fingerprint.

Medicine & Life Sciences